149 related articles for article (PubMed ID: 38688594)
21. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
[TBL] [Abstract][Full Text] [Related]
22. Fibrin-Associated, EBV-Negative Diffuse Large B-Cell Lymphoma Arising in Atrial Myxoma: Expanding the Spectrum of the Entity.
Baugh L; Brown N; Song JY; Pandya S; Montoya V; Perry AM
Int J Surg Pathol; 2022 Feb; 30(1):39-45. PubMed ID: 33913371
[TBL] [Abstract][Full Text] [Related]
23. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract][Full Text] [Related]
24. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.
Hu M; Trevino J; Yang L; Cao D; Liu X; Lai J
In Vivo; 2018; 32(2):413-417. PubMed ID: 29475930
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing.
Wang XN; Hong J; Xu YG; Zhang P; Li YY; Dou HL; Li HP
BMC Ophthalmol; 2024 Mar; 24(1):99. PubMed ID: 38438866
[TBL] [Abstract][Full Text] [Related]
26. EBV-associated diffuse large B-cell lymphoma arising in the chest wall with surgical mesh implant.
Fujimoto M; Haga H; Okamoto M; Obara E; Ishihara M; Mizuta N; Nishimura K; Manabe T
Pathol Int; 2008 Oct; 58(10):668-71. PubMed ID: 18801089
[TBL] [Abstract][Full Text] [Related]
27. Diffuse Large B-Cell Lymphoma Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation.
Lee H; Shin H; Kim NY; Park HS; Park J
Cancer Res Treat; 2019 Oct; 51(4):1666-1670. PubMed ID: 30913860
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?
Monabati A; Vahedi A; Safaei A; Noori S; Mokhtari M; Vahedi L; Zamani M
Asian Pac J Cancer Prev; 2016; 17(4):2285-9. PubMed ID: 27221931
[TBL] [Abstract][Full Text] [Related]
29. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
[TBL] [Abstract][Full Text] [Related]
30. EBV-negative Fibrin-Associated Large B-Cell Lymphoma Arising in Thyroid Hyperplastic Nodule: Report of a Case and Literature Review.
Ho TW; Cheuk W; Chan JKC
Int J Surg Pathol; 2023 Oct; 31(7):1420-1425. PubMed ID: 36843554
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography findings in Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) of the elderly: comparison with EBV-negative DLBCL.
Tokuyama K; Okada F; Sato H; Matsumoto S; Matsumoto A; Haruno A; Kashima K; Ogata M; Ohtsuka E; Mori H
Br J Radiol; 2017 Apr; 90(1072):20160879. PubMed ID: 28256900
[TBL] [Abstract][Full Text] [Related]
32. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.
Castillo JJ; Beltran BE; Miranda RN; Paydas S; Winer ES; Butera JN
Oncologist; 2011; 16(1):87-96. PubMed ID: 21212426
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
Daroontum T; Kohno K; Inaguma Y; Okamoto A; Okamoto M; Kimura Y; Nagahama M; Sakakibara A; Satou A; Nakamura S
Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.
Wills A; Fan G; Kim E; Okada CY; White KP; Hopkins RS
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738840
[TBL] [Abstract][Full Text] [Related]
35. An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markers.
Nakatsuka SI; Yutani C; Kurashige M; Kohara M; Nagano T; Goto T; Takatsuka H; Ifuku H; Morii E
Diagn Pathol; 2017 Jan; 12(1):15. PubMed ID: 28143608
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications.
Volaric AK; Saleem A; Younes SF; Zhao S; Natkunam Y
Ann Diagn Pathol; 2024 Jun; 70():152286. PubMed ID: 38447253
[TBL] [Abstract][Full Text] [Related]
37. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
38. Collision of Lymphoepithelioma-like Carcinoma with Diffuse Large B-cell Lymphoma of the Stomach: A Case Report.
Liu L; Zhao H; Sheng L; Yang P; Zhou H; Wang R
Anticancer Res; 2017 Aug; 37(8):4569-4573. PubMed ID: 28739754
[TBL] [Abstract][Full Text] [Related]
39. Multiple Brain Biopsies for Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma with Extensive Necrosis in a Posttransplant Patient.
Hoang Oanh DT; Jung TY; Kim SK; Yang DH; Kang SR; Lee KH
World Neurosurg; 2020 Jan; 133():10-13. PubMed ID: 31550543
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report.
Yu M; Zhang Q; Xu S; Yin T; Li F
Anticancer Drugs; 2022 Jan; 33(1):e769-e775. PubMed ID: 34387604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
